Trump admin links Tylenol use in pregnancy to increased risk of autism despite mixed studies
The Trump administration made a startling announcement on Monday regarding the use of Tylenol during pregnancy and its potential link to autism. President Donald Trump revealed during a press conference at the White House that the Food and Drug Administration (FDA) will be advising physicians to limit the use of Tylenol in pregnant women unless it is deemed medically necessary.
The FDA will be updating the label for acetaminophen, the active ingredient in Tylenol, to reflect potential benefits in reducing some autism symptoms. However, it is important to note that studies have not definitively proven a cause-and-effect relationship between Tylenol use during pregnancy and the development of autism. While some studies suggest a possible link, major medical groups like the American College of Obstetricians and Gynecologists (ACOG) continue to recommend acetaminophen as the safest painkiller for pregnant women.
Dr. Steven Fleischman, president of ACOG, expressed concerns about the administration’s announcement, stating that it is not supported by the full body of scientific evidence. He emphasized that spreading misinformation about the link between acetaminophen use during pregnancy and autism could be harmful and misleading to pregnant patients.
In response to the administration’s statement, Kenvue, the maker of Tylenol, defended the safety of acetaminophen and disagreed with any suggestions that it causes autism. The company highlighted the importance of acetaminophen as a safe pain reliever option for pregnant women and warned of the potential health risks if it were to be restricted.
In addition to the Tylenol controversy, the administration also announced plans to begin the approval process for a drug called leucovorin, which has shown promise in alleviating symptoms of autism in some children. Despite limited evidence of its benefits, the administration is moving forward with the approval process for leucovorin, a drug commonly used in cancer care.
During the press conference, Trump and Health and Human Services Secretary Robert F. Kennedy Jr. also raised concerns about the childhood vaccine schedule possibly contributing to autism, going against established research that has found no link between vaccines and autism.
As this story continues to unfold, it is important to stay informed and updated on any developments regarding the use of Tylenol during pregnancy and its potential link to autism. Please check back for more updates on this evolving situation.
